Olympic Ophthalmics

Olympic Ophthalmics is a medical device company developing novel treatments for dry eye disease.

Business Model:

Revenue: $0

Employees: 1-10

Rankings

Detailed Olympic Ophthalmics Information

Geographic Data

Olympic Ophthalmics headquarters map

Address:

City: Issaquah

State: Washington

Zip:

Country: United States

Financial Info

Stage:

series a

Raised Last:

$0

Raised Total:

$0

Metrics

9,298,036Website Global Rank

168Website Monthly Traffic

Twitter Followers

Description

Olympic Ophthalmics is a medical device company developing novel treatments for dry eye disease. The company’s focus is to develop devices to treat the signs and symptoms of Dry Eye Disease (DED). It works by stimulating the trigeminal parasympathetic pathway to activate the glands responsible for tear film production. Olympic Ophthalmics was founded in 2017 by Michael Gertner and is based in Issaquah, Washington.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2018 Series A 1 - Morgenthaler Ventures
Morgenthaler Ventures
1/2018 Series A 1 - Morgenthaler Ventures
Morgenthaler Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research